2005
DOI: 10.1097/01.rvi.0000184594.01661.81
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Unresectable Hepatocellular Carcinoma with Use of 90Y Microspheres (TheraSphere): Safety, Tumor Response, and Survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
188
1
6

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 375 publications
(202 citation statements)
references
References 36 publications
7
188
1
6
Order By: Relevance
“…13), 14) For the thermal coagulation therapy, the magnetic materials containing glass ceramics have been studied for the embolization method. Fe 3 O 4 microspheres with a 20 30¯m diameter range were synthesized by melting the powder in a high frequency induction thermal plasma at high temperature and by precipitation from an aqueous solution.…”
Section: )mentioning
confidence: 99%
“…13), 14) For the thermal coagulation therapy, the magnetic materials containing glass ceramics have been studied for the embolization method. Fe 3 O 4 microspheres with a 20 30¯m diameter range were synthesized by melting the powder in a high frequency induction thermal plasma at high temperature and by precipitation from an aqueous solution.…”
Section: )mentioning
confidence: 99%
“…Yttrium-90 microspherers using TheraSphere µ and SIR-Sphere µ have already been used for the radioembolization of liver tumors. 16), 17) In the case of thermal coagulation therapy, magnetic materials containing glass ceramics have been studied for the embolization method. Kawashita et al reported the synthesis of FeFe 2 O 4 microspheres with a 2030¯m diameter range prepared by melting the powder in a high frequency induction thermal plasma and by precipitation from an aqueous solution.…”
Section: )13)mentioning
confidence: 99%
“…Y-90 labeled microsphere radioembolization can provide a safe and effective therapeutic method for both hepatocellular carcinoma and metastatic hepatic tumor [6,[12][13][14][15][16]. In the randomized trial by Hazel et al [12], among patients with hepatic metastasis of colorectal cancer, the group treated with combination regimen of cheomotherapy plus single Y-90 microsphere administration demonstrated significantly increased therapeutic response and survival than the chemotherapy-only control group.…”
Section: Introductionmentioning
confidence: 99%
“…Many hepatic malignant tumors cannot be surgically resected because they are locally advanced or involving both hepatic lobes at the time of diagnosis. A variety of therapeutic methods have been introduced for unresectable hepatic tumors, such as systemic chemotherapy, external radiation therapy, trans-arterial chemoembolization, percutaneous ethanol injection, and percutaneous radiofrequency ablation [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%